Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 9
Submit an article Journal homepage
181
Views
30
CrossRef citations to date
0
Altmetric
Review

B-cell targeting: a novel approach to immune intervention today and tomorrow

Thomas Dörner Charite University Hospital Berlin and Deutsche Rheumaforschungszentrum, Chariteplatz 01, 10098 Berlin, Germany [email protected]
&
Peter E Lipsky NIAMS, NIH, Bethesda, MD, USA
Pages 1287-1299 | Published online: 29 Aug 2007

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Fariha Kausar, Khader Mustafa, Ghaleb Sweis, Ray Sawaqed, Khaldoon Alawneh, Rafah Salloum, Maria Badaracco, Timothy B Niewold & Nadera J Sweiss. (2009) Ocrelizumab: a step forward in the evolution of B-cell therapy. Expert Opinion on Biological Therapy 9:7, pages 889-895.
Read now

Articles from other publishers (29)

Richard J. NowakChristopher S. CoffeyJonathan M. GoldsteinMazen M. Dimachkie, Michael BenatarJohn T. KisselGil I. WolfeTed M. BurnsMiriam L. FreimerSharon NationsVolkan Granit, A. Gordon SmithDavid P. RichmanEmma CiafaloniMuhammad T. Al-LoziLaura Ann SamsDianna QuanEroboghene UboguBrenda PearsonAditi SharmaJon W. YankeyLiz UribeMichael ShyAnthony A. AmatoRobin ConwitKevin C. O'Connor, David A. HaflerMerit E. CudkowiczRichard J. Barohn. (2022) Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis. Neurology 98:4.
Crossref
Kristine Oleinika, Claudia Mauri & Alan D. Salama. (2018) Effector and regulatory B cells in immune-mediated kidney disease. Nature Reviews Nephrology 15:1, pages 11-26.
Crossref
John MacIsaac, Reda Siddiqui, Erin Jamula, Na Li, Steven Baker, Kathryn E. Webert, Denise Evanovitch, Nancy M. Heddle & Donald M. Arnold. (2018) Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin. Transfusion 58:11, pages 2729-2735.
Crossref
Tamaki Ikuse, Yoshikazu Ohtsuka, Naho Obayashi, Keisuke Jimbo, Yo Aoyagi, Takahiro Kudo, Daisuke Asaoka, Mariko Hojo, Akihito Nagahara, Sumio Watanabe, Thomas G Blanchard, Steven J Czinn & Toshiaki Shimizu. (2018) Host response genes associated with nodular gastritis in Helicobacter pylori infection . Pediatrics International 60:5, pages 446-454.
Crossref
Brij Bhushan Mehta, Saniya Sharma, Rakesh K. Vasishta, Ramesh K. Sen, Aman Sharma & Manni Luthra-Guptasarma. (2018) Blocking osteopontin-fibronectin interactions reduce extracellular fibronectin deployment and arthritic immunopathology. International Immunopharmacology 55, pages 297-305.
Crossref
Zhiwei Hu. (2018) Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases. Antibodies 7:1, pages 8.
Crossref
Daniel J Wallace, Kenneth Kalunian, Michelle A Petri, Vibeke Strand, Frederic A Houssiau, Marilyn Pike, Brian Kilgallen, Sabine Bongardt, Anna Barry, Lexy Kelley & Caroline Gordon. (2014) Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study. Annals of the Rheumatic Diseases 73:1, pages 183-190.
Crossref
Mikael Brisslert, Maria Rehnberg & Maria I. Bokarewa. (2013) Epstein-Barr virus infection transforms CD25 + B cells into antibody-secreting cells in rheumatoid arthritis patients . Immunology 140:4, pages 421-429.
Crossref
Richard J. Nowak, Daniel B. DiCapua, Nazlee Zebardast & Jonathan M. Goldstein. (2011) Response of patients with refractory myasthenia gravis to rituximab: a retrospective study. Therapeutic Advances in Neurological Disorders 4:5, pages 259-266.
Crossref
Catarina Dias & David A. Isenberg. (2011) Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma. Nature Reviews Rheumatology 7:6, pages 360-368.
Crossref
Mattias Magnusson, Mikael Brisslert, Kiandoht Zendjanchi, Magnus Lindh & Maria I. Bokarewa. (2010) Epstein–Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment. Rheumatology 49:10, pages 1911-1919.
Crossref
Rei Watanabe, Nobuko Ishiura, Hiroko Nakashima, Yoshihiro Kuwano, Hitoshi Okochi, Kunihiko Tamaki, Shinichi Sato, Thomas F. Tedder & Manabu Fujimoto. (2010) Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity. The Journal of Immunology 184:9, pages 4801-4809.
Crossref
Antonio Fontanellas, Sandra Hervás-Stubbs, Itsaso Mauleón, Juan Dubrot, Uxua Mancheño, María Collantes, Ana Sampedro, Carmen Unzu, Carlos Alfaro, Asis Palazón, Cristian Smerdou, Alberto Benito, Jesús Prieto, Iván Peñuelas & Ignacio Melero. (2010) Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates. Molecular Therapy 18:4, pages 754-765.
Crossref
Taco W. Kuijpers, Richard J. Bende, Paul A. Baars, Annette Grummels, Ingrid A.M. Derks, Koert M. Dolman, Tim Beaumont, Thomas F. Tedder, Carel J.M. van Noesel, Eric Eldering & René A.W. van Lier. (2010) CD20 deficiency in humans results in impaired T cell–independent antibody responses. Journal of Clinical Investigation 120:1, pages 214-222.
Crossref
Heinz Wiendl, Nico Melzer, Christoph Kleinschnitz & Sven G. Meuth. 2010. MULTIPLE SCLEROSIS 3. MULTIPLE SCLEROSIS 3 388 426 .
Nicolas Hunzelmann. 2010. Therapy of Skin Diseases. Therapy of Skin Diseases 427 432 .
Thomas Dörner, David Isenberg, David Jayne, Heinz Wiendl, Detlef Zillikens & Gerd Burmester. (2009) Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis. Autoimmunity Reviews 9:2, pages 82-89.
Crossref
Yasuhiro Take, Ken Nakata, Jun Hashimoto, Hideki Tsuboi, Norihiro Nishimoto, Takahiro Ochi & Hideki Yoshikawa. (2009) Specifically modified osteopontin in rheumatoid arthritis fibroblast‐like synoviocytes supports interaction with B cells and enhances production of interleukin‐6. Arthritis & Rheumatism 60:12, pages 3591-3601.
Crossref
Angela Nagel, Eva Podstawa, Markus Eickmann, Hans-Helge Müller, Michael Hertl & Rüdiger Eming. (2009) Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris. Journal of Investigative Dermatology 129:9, pages 2202-2210.
Crossref
Thomas Dörner, Andreas Radbruch & Gerd R. Burmester. (2009) B-cell-directed therapies for autoimmune disease. Nature Reviews Rheumatology 5:8, pages 433-441.
Crossref
H. Mei & T. Dörner. (2009) Translationale Aspekte zur Rolle von B-Zellen bei AutoimmunerkrankungenTranslational aspects on the role of B-cells in autoimmune diseases. Zeitschrift für Rheumatologie 68:5, pages 364-369.
Crossref
Angela Nagel, Michael Hertl & Rüdiger Eming. (2009) B-Cell-Directed Therapy for Inflammatory Skin Diseases. Journal of Investigative Dermatology 129:2, pages 289-301.
Crossref
Huiming Wang, Zhao Yang, Fan Li, Yani He, Shuguang Wang, Di Yang & Yuzhang Wu. (2009) Insertion of a Targeting Peptide on Capsid Surface Loops of Human Papillomavirus Type-16 Virus-like Particles Mediate Elimination of Anti-dsDNA Abs-producing B Cells With High Efficiency. Journal of Immunotherapy 32:1, pages 36-41.
Crossref
Thomas Dörner & Peter E. Lipsky. 2009. Rheumatoid Arthritis. Rheumatoid Arthritis 97 106 .
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:6, pages 590-596.
Crossref
Kazuhiro Komura, Koichi Yanaba, Mayuka Horikawa, Fumihide Ogawa, Manabu Fujimoto, Thomas F. Tedder & Shinichi Sato. (2008) CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model. Arthritis & Rheumatism 58:11, pages 3574-3584.
Crossref
Georg Schett, Christian Stach, Jochen Zwerina, Reinhard Voll & Bernhard Manger. (2008) How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis & Rheumatism 58:10, pages 2936-2948.
Crossref
Robert M. Sharkey, Habibe Karacay, Samuel Litwin, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang & David M. Goldenberg. (2008) Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody. Cancer Research 68:13, pages 5282-5290.
Crossref
Thomas Dörner & Gerd R Burmester. (2008) New approaches of B-cell-directed therapy: beyond rituximab. Current Opinion in Rheumatology 20:3, pages 263-268.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.